Back to calendar
Halozyme Therapeutics, Inc. (HALO) Earnings
HALO reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $1.79
Actual EPS: $1.60
EPS surprise: 3.56%
Company overview
Market Cap$9.9B
PriceUSD 83.44
P/E30.01
EPS (TTM)2.78
52-week high84.44
52-week low58.53
SectorHealth Technology
IndustryBiotechnology
Employees423